Stay updated on Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page displays a new Revision: v3.6.3, indicating an internal update to the ClinicalTrials.gov page. This change does not affect the study details shown.
    Difference
    0.1%
    Check dated 2026-07-04T13:17:03.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2. This indicates a minor update to the page version rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-06-27T07:57:25.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    New help and navigation sections were added to the study page, and the Intervention/Treatment heading was reformatted; an older revision label was removed in favor of the updated site version.
    Difference
    0.5%
    Check dated 2026-06-13T05:12:04.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small internal update to the ClinicalTrials.gov page without altering the study information.
    Difference
    0.1%
    Check dated 2026-06-05T22:17:10.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the page. This update appears to be a minor metadata change without altering the reported study details or layout.
    Difference
    0.1%
    Check dated 2026-05-15T15:35:37.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The collaborators list was updated to replace Instituto de Patologia e Imunologia Molecular da Universidade do Porto with Universidade do Porto as a study collaborator.
    Difference
    0.1%
    Check dated 2026-05-01T10:00:38.000Z thumbnail image

Stay in the know with updates to Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.